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1. Introduction 
The transport of 2-oxoglutarate across the inner 
membrane of rat liver mitochondria is mediated by a 
specific carrier system which is activated by phos 
phate and L-malate [l-4]. 2-n-Butyl malonate inhi- 
bits this carrier by competition with the malate acti- 
vator [5] . 
In this communication, evidence is presented that 
the entry of oxoglutarate into mitochondria is speci- 
fically inhibited by L-aspartate. The inhibition is 
competitive with respect to oxoglutarate (Ki = 
0.15 mM), and non-competitive with respect to L 
malate or malonate. Externally added aspartate does 
not appear to influence oxoglutarate efflux from 
mitochondria. It is suggested that in vivo the oxo- 
glutarate carrier is effectively unidirectional. 
2. Methods 
Rat liver mitochondria were prepared as described 
by Chappell and Hansford [6]. Changes in the redox 
state of the intramitochondrial nicotinamide nucleo- 
tides were monitored by double-beam spectrophot+ 
metry at 340-373 rnp. Oxoglutarate and Laspartate 
were assayed enzymatically. 
3. Results 
The rate of reduction of intramitochondrial NAD(P) 
by externally added oxoglutarate together with 
malonate (to activate oxoglutarate entry) (fig. l(A)) 
was considerably slower if Laspartate was added be- 
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Fig. 1. Effect of L-aspartate on the reduction of intramito- 
chondriai NAD(P) by oxoglutarate in the presence of malo- 
nate. Rat liver mitochondria (6 mg) were suspended in a me- 
dium containing 120 mM-KCI, 20 mM-tris chloride and 
5 mM-tris phosphate, pH 7.4 in the cuvette of a double- 
beam spectrophotometer. The total volume was 2.5 ml. 
1pM FCCP was added and after a 3 min incubation at 30°C. 
this was followed by 0.5 I.rg antimycin (not shown). Further 
additions were hydroxylamine (1 mM), oxoglutarate (0.5 
mM), aspartate (1 mM) and malonate (1 mM). The recorder 
was reset after the oxoglutarate addition which caused a 
non-specific absorbancy change. 
fore the oxoglutarate (fig. l(B)). Similar results were 
obtained using L-malate as activator. In this type of 
experiment, it was essential to prevent the possibility 
of transamination between oxoglutarate and aspar- 
tate. This was achieved by prior addition of 1 mM 
hydroxylamine or 1 mM KCN, either of which vir- 
tually completely inhibited the mitochondrial aspar- 
tate aminotransferase. Control experiments with 
ultrasonically treated mitochondria showed that as- 
partate in the presence of KCN did not significantly 
inhibit the activity of oxoglutarate dehydrogenase. 
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Fig. 2. Effect of the order of addition of reagents on the oxi- 
dation of intramitochondrial NAD(P)H. The mitochondria 
were incubated with FCCP as in fig. 1, and antimycin was ad- 
ded after 3 minutes. Further additions were 3-hydroxy- 
butyrate (2 mM), oxoglutarate (1 mM), malonate (1 mM), 
glutamate (1 mM), aspartate (1 mM). The temperature was 
3o”c. 
Fig. 2(A) shows that when the intramitochondrial 
nucleotides were reduced by the addition of 3-hy- 
droxybutyrate, the addition of oxoglutarate together 
with malonate followed by glutamate (to activate 
aspartate entry [7]) and aspartate led to a rapid reoxi- 
dation of NADH. This oxidation was due to the pro- 
duction of oxaloacetate by the transamination of 
oxoglutarate and aspartate. Fig. 2(B) shows the same 
experiment except that aspartate was added before 
oxoglutarate. The rate of NADH oxidation was 
slower, suggesting that the access of oxoglutarate to 
the transaminase was inhibited by aspartate. 
Glutamate entry was not inhibited by aspartate. 
Similarly, it was shown that the oxidation of 
NAD(P)H (in intact mitochondria) on the addition of 
oxoglutarate together with malonate and NH:, due 
to the action of glutamate dehydrogenase, was in- 
hibited by aspartate. Glutamate dehydrogenase acti- 
vity of ultrasonically or triton-treated mitochondria 
was not affected by aspartate. Again hydroxylamine 
was present to prevent transamination. Thus the 
interaction of oxoglutarate with the intramitochon- 
drial enzymes aspartate aminotransferase, oxo- 
glutarate and glutamate dehydrogenase was inhibited 
by the prior addition of aspartate, suggesting that 
aspartate was inhibiting oxoglutarate entry. The in- 
hibition was specific to the oxoglutarate carrier, in 
that the entry of citrate, glutamate or malate was not 
inhibited by aspartate. 
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Fig. 3. Penetration of the water of mitochondrial pellets by 
oxoglutarate in the presence of malonate, and the inhibitory 
effect of aspartate. Mitochondria (20 mg) were incubated for 
5 min at 20°C in a medium containing 120 mM-KU, 
20 mM-tris chloride, 5 mM-oxoglutarate, 5 mM-malonate, 
5 mM phosphate, 1 mM hydroxylamine, 1 mM arsenite, anti- 
mycin (0.5 pg) and rotenone (1 pg) in a total volume of 
3 ml pH 7.4. The incubation medium also contained 14C- 
labelled sucrose and tritiated water and in some experiments 
5 mM-aspartate was also present. The mitochondria were 
sedimented by centrifugntion, and oxoglutarate, 14C-labelled 
sucrose and tritiated water were determined in the pellet 
and supernatant after deproteinisation with perchloric acid. 
For details, see Chappell et al. (31. 
In experiments similar to those in fig. 1 it appear- 
ed that the extent of the inhibition depended on the 
relative concentrations of oxoglutarate and aspartate. 
Plots of the reciprocal of the rate of NAD(P) reduc- 
tion against inhibitor (aspartate) concentration 
showed that the inhibition was competitive with 
respect to oxoglutarate (Ki = 0.15 mM), and non- 
competitive with respect to malate or malonate. 
The intramitochondrial volume available to oxo- 
glutarate was determined as described by Chappell 
[4], using f4C-labelled sucrose and 3H20 as markers. 
In the absence of aspartate, oxoglutarate penetrated 
the mitochondria to the same extent as 3H20 (see 
also [3] ). However in the presence of aspartate the 
extent of oxoglutarate penetration was reduced to a 
level only slightly above that of 14C-labelled sucrose 
(fig. 3). 
The inhibition of oxoglutarate entry by aspartate 
could be demonstrated also by the ammonium swel- 
ling technique [ 21. Thus the rate of swelling of mito- 
chondria in a medium containing 50 mM ammonium 
oxoglutarate and 70 mM NH4C1 was much faster than 
that in 50 mM NH: oxoglutarate and 50 mM NH, as- 
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Fig. 4. Postulated “shuttle” for the transfer of reducing equivalents across the mitochondrial membrane [ 12,3,4] . Activating effects 
of compounds on carriers are indicated by wavy arrows with a positive sign, and inhibition by wavy arrows with a negative sign. 
I malate transporter 
II glutamate transporter 
111 aspartate transporter, glutamate activated 
IV oxoglutarate transporter, malate activated, 
entry of oxoglutarate inhibited by aspartate. 
partate (Cl- is a non-penetrant). Swelling was initiated 
by the addition of 2 mM malate, and 2 mM NH: phos- 
phate was present initially. 
When glutamate is oxidised in the presence of arse- 
nite and excess ADP and phosphate, oxoglutarate 
accumulates in the mitochondria and after 3-5 minutes 
the rate of oxoglutarate production is equal to the 
rate of oxoglutarate efflux from the mitochondria [9]. 
In such experiments it was found that the addition of 
5 mM aspartate to a mitochondrial suspension oxidis- 
ing glutamate in the presence of arsenite did not inhi- 
bit the rate of oxoglutarate production when malonate 
was present, in the presence or absence of a tran+ 
aminase inhibitor. In further similar experiments, the 
distribution of oxoglutarate with time was measured 
in the presence and absence of aspartate. No signifi- 
cant difference was found. Thus externally added as- 
partate did not influence oxoglutarate efflux, suggest- 
ing that oxoglutarate and aspartate must be on the 
same side of the membrane for inhibition to occur. 
Under no metabolic conditions investigated could 
1: malate dehydrogenase 
2: aspartate aminotransferase 
OAA: oxaloacetate. 
a significant intramitochondrial aspartate concentra- 
tion be detected. For example, when mitochondria 
oxidise malate in the presence of glutamate, the 
oxaloacetate formed is transaminated with the 
glutamate to form oxoglutarate and aspartate. How- 
ever, measurements of aspartate distribution showed 
that practically all the aspartate formed was outside 
the mitochondria. The very low concentrations of 
aspartate observed inside mitochondria indicate that 
oxoglutarate efflux could not be inhibited by aspar- 
tate. 
The concentration of oxoglutarate in the normal 
rat liver is approximately 0.25 mM [lo] with an 
apparent Km for entry of approximately 0.1 mM, and 
the intracellular concentration of aspartate is 
approximately 2 mM [ 111 . Thus it appears that in 
vim, the carrier promotes oxoglutarate efflux much 
faster than its entry (if the intramitochondrial as- 
partate level is indeed low) i.e. the carrier is effective- 
ly unidirectional. 
It has been suggested that the transfer of reducing 
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equivalents between the cytosol and the mitochondria 
occurs by the system shown in fig. 4 [ 12,3,4] . One of 
the problems with this system is to account for the 
considerable difference in redox state of the NAD in 
the two compartments (see [lo]). In part, the energy- 
linked accumulation of malate (B.H.Robinson - un- 
published observations), the observed exclusion of as- 
partate from the mitochondrion and the inhibition of 
oxoglutarate entry (but not efflux) by aspartate may 
be responsible for the relatively high degree of reduc- 
tion of intramitochondrial NAD. 
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